Production (Stage)
PROCEPT BioRobotics Corporation
PRCT
$57.38
-$0.34-0.59%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 249.12M | 224.50M | 199.84M | 176.58M | 156.33M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 249.12M | 224.50M | 199.84M | 176.58M | 156.33M |
| Cost of Revenue | 92.90M | 87.40M | 85.16M | 79.93M | 72.73M |
| Gross Profit | 156.23M | 137.10M | 114.68M | 96.65M | 83.59M |
| SG&A Expenses | 187.01M | 171.42M | 159.42M | 149.61M | 141.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 345.52M | 321.11M | 306.30M | 286.22M | 264.77M |
| Operating Income | -96.40M | -96.61M | -106.46M | -109.64M | -108.44M |
| Income Before Tax | -90.19M | -91.41M | -100.06M | -103.71M | -103.37M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -90.19 | -91.41 | -100.06 | -103.71 | -103.37 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -90.19M | -91.41M | -100.06M | -103.71M | -103.37M |
| EBIT | -96.40M | -96.61M | -106.46M | -109.64M | -108.44M |
| EBITDA | -90.88M | -91.38M | -101.36M | -104.82M | -104.24M |
| EPS Basic | -1.70 | -1.76 | -1.95 | -2.06 | -2.12 |
| Normalized Basic EPS | -1.06 | -1.10 | -1.22 | -1.29 | -1.33 |
| EPS Diluted | -1.70 | -1.76 | -1.95 | -2.06 | -2.12 |
| Normalized Diluted EPS | -1.06 | -1.10 | -1.22 | -1.29 | -1.33 |
| Average Basic Shares Outstanding | 212.39M | 208.48M | 205.23M | 201.53M | 195.07M |
| Average Diluted Shares Outstanding | 212.39M | 208.48M | 205.23M | 201.53M | 195.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |